logo-loader
viewEland Oil & Gas PLC

Investor Update: Woodford's troubled equity income fund to be shut down

Headlines from the Proactive UK newsroom.

Neil Woodford's troubled equity income fund is to be wound up as part of a fire sale -- its adviser Link Fund Solutions has announced. Investors have not been able to make withdrawals since early June due to its problems.

Nigeria-focused oil group Eland (LON:ELA) is to be bought by rival local Seplat in a deal worth £382mln. The cash offer is worth 166p per share compared to last night’s close of 129p.

Opioid dependency drug group Indivior (LON:INDV) has upped its profits and sales forecasts as lead drug Suboxone is fighting off generic competition better than expected. 

Brain scan software specialist IXICO (LON:IXI) will post its first annual underlying profit since it listed after revenues in its latest year surged 40% to £7.6 million.

Car dealers and brokers are facing a clampdown on commissions they receive for arranging loans to buy a car.  The Financial Conduct Authority estimates the ban will save consumers £165mln a year.

Crossword Cybersecurity (LON:CCS) has signed a Memorandum of Understanding with major aerospace group Leonardo. The Italian group will use Crossword’s Rizkon product to carry out risk assessments on its suppliers.

Quick facts: Eland Oil & Gas PLC

Price: 164.6 GBX

AIM:ELA
Market: AIM
Market Cap: £354.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eland Oil & Gas PLC named herein, including the promotion by the Company of Eland Oil & Gas PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Pharma giant Novo Nordisk extends contract with e-Therapeutics

Headlines from the Proactive Investors UK newsroom. E-therapeutics (LON:ETX) has extended its collaboration with Novo Nordisk to investigate new therapeutic approaches for type 2 diabetes. It is the first research agreement for e-therapeutics' new functional genomics technology. Eland Oil...

on 1/8/19

2 min read